Annie Rassing Hoelgaard

Title: Annie Rassing Hoelgaard: Innovator in Pharmaceutical Formulations

Introduction

Annie Rassing Hoelgaard is a notable inventor based in Holte, Denmark. She has made significant contributions to the field of pharmaceutical formulations, particularly in the stability of growth hormones. With a total of 2 patents, her work has garnered attention for its innovative approaches to enhancing the efficacy and stability of pharmaceutical products.

Latest Patents

Annie's latest patents focus on a pharmaceutical preparation that includes a growth hormone and histidine or a derivative of histidine as an additive or buffering substance. This formulation demonstrates exceptional stability against deamidation, oxidation, and cleavage of peptide bonds. The stability of the product allows for storage and shipment in a lyophilized state or as a dissolved preparation at ambient temperature. Furthermore, the crystallization of growth hormone in the presence of histidine or its derivatives results in a higher yield of crystals with greater purity compared to existing methods.

Career Highlights

Annie Rassing Hoelgaard is currently associated with Novo Nordisk A/S, a leading global healthcare company. Her work at Novo Nordisk has been instrumental in advancing pharmaceutical formulations that improve patient outcomes.

Collaborations

Annie collaborates with esteemed colleagues such as Hans Holmegaard So Slashedrensen and Lars Skriver, contributing to a dynamic research environment that fosters innovation.

Conclusion

Annie Rassing Hoelgaard's contributions to pharmaceutical formulations highlight her role as a pioneering inventor in the field. Her innovative approaches continue to influence the development of stable and effective pharmaceutical products.